| Year |
Title |
Altmetric |
| 2023
|
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease.
American Journal of Kidney Diseases.
81:318-328.e1.
2023
|
|
| 2023
|
Adverse childhood experiences are associated with vascular changes in adolescents that are risk factors for future cardiovascular disease.
Pediatric Nephrology.
2023
|
|
| 2023
|
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network.
American Journal of Kidney Diseases.
2023
|
|
| 2023
|
Genetic testing in children with nephrolithiasis and nephrocalcinosis.
Pediatric Nephrology.
2023
|
|
| 2022
|
Kidney implications of SARS-CoV2 infection in children.
Pediatric Nephrology.
37:1453-1467.
2022
|
|
| 2021
|
Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.
Arthritis and Rheumatology.
73:1514-1522.
2021
|
|
| 2021
|
Hyperuricemia and abnormal nocturnal dipping impact glomerular filtration rate in patients with sickle cell anemia.
American Journal of Hematology.
96:E143-E146.
2021
|
|
| 2021
|
Trends in Blood Pressure and Hypertension among US Children and Adolescents, 1999-2018.
JAMA Network Open.
4.
2021
|
|
| 2020
|
The editorialist replies.
New England Journal of Medicine.
383:1692.
2020
|
|
| 2020
|
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study.
Kidney International Reports.
5:1679-1689.
2020
|
|
| 2020
|
Reply to ‘The case for evidence-based medicine for the association between hyperuricaemia and CKD’.
Nature Reviews Nephrology.
16:422-423.
2020
|
|
| 2020
|
Uric acid and hypertension: An update with recommendations.
American Journal of Hypertension.
33:583-594.
2020
|
|
| 2020
|
Urate-lowering therapy and chronic kidney disease progression.
New England Journal of Medicine.
382:2567-2568.
2020
|
|
| 2020
|
Persistent Disease Activity in Patients With Long-Standing Glomerular Disease.
Kidney International Reports.
5:860-871.
2020
|
|
| 2020
|
Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients.
Pediatric Nephrology.
35:883-889.
2020
|
|
| 2019
|
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.
Nature Reviews Nephrology.
15:767-775.
2019
|
|
| 2019
|
Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis.
Pediatric Transplantation.
23.
2019
|
|
| 2019
|
Health-related quality of life in glomerular disease.
Kidney International.
95:1209-1224.
2019
|
|
| 2019
|
Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.
American Journal of Hematology.
94:417-423.
2019
|
|
| 2019
|
Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients.
American Journal of Transplantation.
19:1218-1223.
2019
|
|
| 2019
|
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
American Journal of Kidney Diseases.
73:218-229.
2019
|
|
| 2019
|
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients.
Pediatric Transplantation.
23.
2019
|
|
| 2018
|
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature
2018
|
|
| 2018
|
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.
Kidney International Reports.
3:1373-1384.
2018
|
|
| 2018
|
Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation.
American Journal of Transplantation.
18:2189-2199.
2018
|
|
| 2017
|
Effect of Febuxostat on ambulatory blood pressure in subjects with hyperuricemia and hypertension: A Phase 2 randomized placebo-controlled study.
Journal of the American Heart Association.
6.
2017
|
|
| 2017
|
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.
Pediatric Nephrology.
32:1565-1573.
2017
|
|
| 2017
|
Added sugars and cardiovascular disease risk in children: A scientific statement from the American Heart Association.
Circulation.
135:e1017-e1034.
2017
|
|
| 2017
|
Severe anemia early in life as a risk factor for sickle-cell kidney disease.
Blood.
129:385-387.
2017
|
|
| 2017
|
Uric Acid Excretion Predicts Increased Blood Pressure Among American Adolescents of African Descent.
American Journal of the Medical Sciences.
353:336-341.
2017
|
|
| 2016
|
The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.
Contemporary Clinical Trials.
50:238-244.
2016
|
|
| 2016
|
Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome.
Pediatric Nephrology.
31:1363-1368.
2016
|
|
| 2016
|
Smaller circuits for smaller patients: improving renal support therapy with Aquadex™.
Pediatric Nephrology.
31:853-860.
2016
|
|
| 2016
|
Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures.
Journal of the American Society of Hypertension.
10:101-107.
2016
|
|
| 2015
|
Serum uric acid and risk of CKD in type 2 diabetes.
Clinical Journal of the American Society of Nephrology.
10:1921-1929.
2015
|
|
| 2015
|
Pharmacokinetics, pharmacodynamics, and safety of lisinopril in pediatric kidney transplant patients: Implications for starting dose selection.
Clinical Pharmacology and Therapeutics.
98:25-33.
2015
|
|
| 2014
|
Serum uric acid and the risk of hypertension and chronic kidney disease.
Current Opinion in Rheumatology.
26:176-185.
2014
|
|
| 2013
|
Serum urate: A biomarker or treatment target in pediatric hypertension?.
Current Opinion in Cardiology.
28:433-438.
2013
|
|
| 2013
|
The utility of cortical-sparing adrenalectomy in pheochromocytomas associated with genetic syndromes.
Journal of Pediatric Surgery.
48:1422-1425.
2013
|
|
| 2013
|
Uric acid and the origins of hypertension.
Journal of Pediatrics.
162:896-902.
2013
|
|
| 2013
|
What are the key arguments against uric acid as a true risk factor for hypertension?.
Hypertension.
61:948-951.
2013
|
|
| 2012
|
Hyperuricemia and Hypertension.
Advances in Chronic Kidney Disease.
19:377-385.
2012
|
|
| 2012
|
Uric acid reduction rectifies prehypertension in obese adolescents.
Hypertension.
60:1148-1156.
2012
|
|
| 2012
|
The Role of Uric Acid in the Pathogenesis of Hypertension in the Young.
Journal of the CardioMetabolic Syndrome.
14:346-352.
2012
|
|
| 2012
|
Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.
American Journal of Human Genetics.
90:836-846.
2012
|
|
| 2012
|
Association between left ventricular mass index and cardiac function in pediatric dialysis patients.
Pediatric Nephrology.
27:835-841.
2012
|
|
| 2011
|
Uric acid: A clinically useful marker to distinguish preeclampsia from gestational hypertension.
Hypertension.
58:548-549.
2011
|
|
| 2011
|
Uric Acid and Hypertension.
Seminars in Nephrology.
31:441-446.
2011
|
|
| 2011
|
Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients.
Pediatric Nephrology.
26:1123-1128.
2011
|
|
| 2011
|
Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.
Pediatric Critical Care Medicine.
12:28-32.
2011
|
|
| 2010
|
Sugar-sweetened beverages and hypertension.
Future Cardiology.
6:773-776.
2010
|
|
| 2010
|
Uric acid and hypertension: Cause or effect?.
Current Rheumatology Reports.
12:108-117.
2010
|
|
| 2010
|
Pediatrics: Uncontrolled hypertension in children on hemodialysis.
Nature Reviews Nephrology.
6:7-8.
2010
|
|
| 2009
|
Uric acid: A novel mediator and marker of risk in chronic kidney disease?.
Current Opinion in Nephrology and Hypertension.
18:526-530.
2009
|
|
| 2009
|
A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid
2009
|
|
| 2009
|
Sour Notes on Sweet Drinks.
Journal of Pediatrics.
154:783-784.
2009
|
|
| 2009
|
Prenatal programming: Maybe not so hopeless after all?.
American Journal of Hypertension.
22:348.
2009
|
|
| 2009
|
Minimal change disease with IgM+ immunofluorescence: A subtype of nephrotic syndrome.
Pediatric Nephrology.
24:1187-1192.
2009
|
|
| 2009
|
Hypothesis: Could excessive fructose intake and uric acid cause type 2 diabetes?.
Endocrine Reviews.
30:96-116.
2009
|
|
| 2009
|
Letter to the editors.
New England Journal of Medicine.
360:540-541.
2009
|
|
| 2009
|
Allopurinol and the role of uric acid in hypertension: Reply.
Journal of the American Medical Association.
301:270-271.
2009
|
|
| 2008
|
Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children.
Pediatrics.
122:1177-1181.
2008
|
|
| 2008
|
Medical progress: Uric acid and cardiovascular risk.
New England Journal of Medicine.
359:1811-1821.
2008
|
|
| 2008
|
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: A randomized trial.
Journal of the American Medical Association.
300:924-932.
2008
|
|
| 2008
|
Frequent hemodialysis with NxStage™ system in pediatric patients receiving maintenance hemodialysis.
Pediatric Nephrology.
23:129-135.
2008
|
|
| 2008
|
Pathogenesis of essential hypertension: Historical paradigms and modern insights.
Journal of Hypertension.
26:381-391.
2008
|
|
| 2007
|
Recent advances in the diagnosis and treatment of pheochromocytoma in children
2007
|
|
| 2007
|
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease1-3.
American Journal of Clinical Nutrition.
86:899-906.
2007
|
|
| 2007
|
Coincident activation of Th2 T cells with onset of the disease and differential expression of GRO-gamma in peripheral blood leukocytes in minimal change disease.
American Journal of Nephrology.
27:253-261.
2007
|
|
| 2007
|
Inaccuracy in pediatric outpatient blood pressure measurement.
Pediatrics.
119.
2007
|
|
| 2007
|
The Role of Uric Acid in Pediatric Hypertension.
Journal of Renal Nutrition.
17:79-83.
2007
|
|
| 2006
|
Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension.
Hypertension.
48:25-26.
2006
|
|
| 2006
|
Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease.
Kidney International.
69:1722-1725.
2006
|
|
| 2006
|
Uric acid and hypertension.
Current Hypertension Reports.
8:111-115.
2006
|
|
| 2006
|
Childhood hypertension is not a silent disease.
Pediatric Nephrology.
21:527-532.
2006
|
|
| 2006
|
Serum uric acid: A risk factor and a target for treatment?.
Journal of the American Society of Nephrology.
17.
2006
|
|
| 2006
|
3-5 year longitudinal follow-up of pediatric patients after acute renal failure.
Kidney International.
69:184-189.
2006
|
|
| 2006
|
A causal role for uric acid in fructose-induced metabolic syndrome
2006
|
|
| 2006
|
Hormonal and cytokine effects of uric acid.
Current Opinion in Nephrology and Hypertension.
15:30-33.
2006
|
|
| 2005
|
Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.
Hypertension.
45:326-330.
2005
|
|
| 2005
|
A unifying pathway for essential hypertension.
American Journal of Hypertension.
18:431-440.
2005
|
|
| 2005
|
Resurrection of uric acid as a causal risk factor in essential hypertension.
Hypertension.
45:18-20.
2005
|
|
| 2005
|
Uric acid and hypertension in adolescents.
Seminars in Nephrology.
25:32-38.
2005
|
|
| 2004
|
Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
Nephrology.
9:394-399.
2004
|
|
| 2004
|
Calcium oxalate deposition in renal allografts: Morphologic spectrum and clinical implications.
American Journal of Transplantation.
4:1338-1344.
2004
|
|
| 2004
|
Diuretic-induced hyperuricemia does not decrease cardiovascular risk..
Journal of Hypertension.
22:1415-1417.
2004
|
|
| 2004
|
Management of a Severe Carbamazepine Overdose Using Albumin-Enhanced Continuous Venovenous Hemodialysis.
Pediatrics.
113:406-409.
2004
|
|
| 2004
|
Diuretic-induced hyperuricemia does not decrease cardiovascular risk [2] (multiple letters).
Journal of Hypertension.
22:1415-1419.
2004
|
|
| 2004
|
Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension.
Kidney International.
66:281-287.
2004
|
|
| 2003
|
Hyperuricemia in childhood primary hypertension.
Hypertension.
42:247-252.
2003
|
|
| 2003
|
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.
Hypertension.
41:1183-1190.
2003
|
|
| 1994
|
Reverse chemical mutagenesis: Identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA
1994
|
|
| 1994
|
Reactive oxygen species in tumorigenesis..
Cancer Research.
54:1890s-1894s.
1994
|
|
| 1994
|
Oxygen radical induced mutagenesis is DNA polymerase specific.
Journal of Molecular Biology.
235:33-41.
1994
|
|
| 1994
|
Mutagenesis by metal-induced oxygen radicals.
Environmental Health Perspectives.
102:57-61.
1994
|
|
| 1993
|
Mechanisms of Mutation by Oxidative DNA Damage: Reduced Fidelity of Mammalian DNA Polymerase β.
Biochemistry.
32:4466-4473.
1993
|
|
| 1988
|
The C proteins of heterogeneous nuclear ribonucleoprotein complexes interact with RNA sequences downstream of polyadenylation cleavage sites.
Molecular and Cellular Biology.
8:4477-4483.
1988
|
|
